Renal Cell Carcinoma (Ongoing)

Posted On 2022-07-06 16:22:57



This special series on “Renal Cell Carcinoma” is edited by Prof. Stênio de Cássio Zequi from Urology Division and Referral Center for Urological Tumors, A.C. Camargo Cancer Center (ACCCC), São Paulo, Brazil.

Stênio de Cássio Zequi
Urology Division and Referral Center for Urological Tumors, A.C. Camargo Cancer Center (ACCCC), São Paulo, Brazil

  • Head of Urology Division and Referral Center for Urological Tumors-A.C. Camargo Cancer Center (ACCCC)-São Paulo-SP- Brazil
  • Coordinator of Robotic Surgery and HIFU Programs -ACCCC
  • Tutor of Graduate Schools:  Antônio Prudente Foundation-SP-(ACCCC), and from Escola Paulista de Medicina- Federal University of São Paulo
  • Founder and Coordinator of LARCG Latin American Renal Cancer Group
  • Medical Advisory Board from IKCC- International kidney Cancer Coalition
  • Researcher from Instituto Nacional de Ciência e Tecnologia em Oncogenômica e Inovação Terapêutica - INCIT - INOTE, A. C. Camargo Cancer Center, Fundação A. Prudente, São Paulo, Brasil.
  • Director for Cryotherapy and Hifu from Brazilian Society of Urology (2019-2023)
  • Livre Docente Professor-University of São Paulo-USP/FMRP

Series outline:

  1. Cystic renal mass Bosniak II F-III and IV: surgery/ablation or active surveillance
  2. Pathology of renal cell carcinoma ( biopsy, primary tumor and metástases)
  3. When radical nephrectomy is preferable than nephron sparing surgeries
  4. Local recurrence of kidney cancer: best management
  5. Lymphadenectomy in kidney cancer: diagnostic and therapeutic role
  6. Options for surgical treatment of renal cell carcinoma with vena cava thrombus levels 3-4
  7. First-line systemic therapy for renal cell carcinoma
  8. Second line and beyond systemic therapies for renal cell carcinoma
  9. Microbiota and kidney cancer: state of the art
  10. Percutaneous irreversible electroporation and microwave ablations for renal carcinoma: will these techniques supplant cryotherapy or radiofrequency?
  11. Cytoreductive nephrectomy
  12. Prognostic factors in Latin American with localized and advanced kidney cancer patients

Disclosure:
The series “Renal Cell Carcinoma” was commissioned by the editorial office, AME Medical Journal without any funding or sponsorship. Stênio de Cássio Zequi is serving as the unpaid Guest Editor for the series.